Treatment Of Oropharyngeal Candidiasis By Oravig (Miconazole) Buccal Tablets

Treatment Of Oropharyngeal Candidiasis By Oravig (Miconazole) Buccal Tablets.
Strativa Pharmaceuticals today announced that the US Food and Drug Administration (FDA) has approved Oravig (miconazole) buccal tablets for the therapy of oropharyngeal candidiasis (OPC), more commonly known as thrush, in adults and children epoch 16 and older fav-store. Oravig is the blue ribbon and only local, viva voce instruction formulation of miconazole - an antifungal medication - approved for this use in the US.

Oravig, which adheres to the gum, utilizes innovative buccal slab technology enabling once-daily dosing that delivers miconazole promptly at the county location of infection throughout the daytime with tiniest systemic absorption articles. Oravig is easy-to-use and provides patients with a flavorless, odorless and helpful healing recourse that does not set back with constantly activities such as eating and drinking.

Oravig will be offered in a 50 mg dosage talent and is expected to be to hand in retail pharmacies in the third billet of 2010. "The FDA green light of Oravig underscores Strativa's commitment to improving patients' overall remedying participation by bringing to market new products that fulfill unaggressive needs," said John A MacPhee, President, Strativa Pharmaceuticals advertising publishing. "Oravig offers patients agony from thrush a proven actual care in a discreet and reach once-daily formulation".

The FDA approval was based on two essential Phase III clinical trials. The commencement study demonstrated that Oravig utterly resolved signs and symptoms of OPC at rates alike to Mycelex Troche (clotrimazole) administered five times per period in HIV-positive patients. This randomized, double-blind, double-dummy distress was conducted in 577 HIV-positive patients in 28 sites in the United States, Canada, and South Africa. A following randomized, open-label, multicenter comparative nuisance conducted in 282 patients who underwent radiotherapy for go and neck cancer showed that Oravig is vault and useful in this long-suffering people who often has reduced salivary flow.